Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01123850 · ClinicalTrials.gov registry record · Phase 2
CopiOs Posterolateral Fusion Procedure
A Phase 2 study, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01123850 is a Phase 2 study that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 45 participants.
The verdict
NCT01123850, a Phase 2 study, was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
To compare radiographic data collection from patients undergoing instrumented PLF with CopiOs(R) BVF or instrumented PLF with autologous bone and to assess overall clinical outcomes. Patients will serve as self controls.
Interventions
- DEVICE Copios
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01123850
The ClinicalTrials.gov registry entry for NCT01123850 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Copios is the first listed.
NCT01123850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01123850 about?
NCT01123850 is a clinical study titled "CopiOs Posterolateral Fusion Procedure". To compare radiographic data collection from patients undergoing instrumented PLF with CopiOs(R) BVF or instrumented PLF with autologous bone and to assess overall clinical outcomes. Patients will serve as self controls.
What is the current status of trial NCT01123850?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2010-06. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01123850?
The interventions under investigation include: Copios (DEVICE).
Who is sponsoring clinical trial NCT01123850?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.